Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.28 0.03 (2.4%) Market Cap: 18.04 Mil Enterprise Value: 21.85 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 51/100

Q4 2018 Cumberland Pharmaceuticals Inc Earnings Call Transcript

Feb 26, 2019 / 09:30PM GMT
Release Date Price: $5.4 (-2.88%)
Operator

Thank you for joining the Cumberland Pharmaceuticals Fourth Quarter 2018 Financial Report and Corporate Update. Please note that this call is being recorded at the company's request and will be archived on Cumberland's website for 1 week from today.

I would like to now introduce Erin Smith, who handles Corporate Relations at Cumberland. Erin, please go ahead.

Erin Smith
Cumberland Pharmaceuticals Inc. - Senior Corporate Relations Associate

Hello, everyone. Today, we issued a press release featuring our fourth quarter 2018 financial results and our company update. That release, including the financial tables that are related to it, is available on our website at www.cumberlandpharma.com.

Before we begin today, I'd like to share the following safe harbor language. This call may contain forward-looking statements within the meaning of the Private Securities Reform Act of 1995. And because the statements in today's call reflect the company's current views and expectations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot